Skip to main content

Legal & General Group Plc

Position in KROS — Keros Therapeutics, Inc.

CIK 764068 London, X0

Position in KROS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$89,986
+$61,051 QoQ
Shares Held
8,410
+220.9% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. KROS ranks #166 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,986 8,410
2026-03-31 $28,935 2,621
2025-12-31 $53,363 2,621
2025-09-30 $49,310 3,117
2025-06-30 $41,611 3,117
2025-03-31 $60,670 5,954
2024-12-31 $506,083 31,970
2024-09-30 $1,690,706 29,115
2024-06-30 $1,330,555 29,115
2024-03-31 $1,685,120 25,455
2023-12-31 $750,508 18,876
2023-09-30 $603,359 18,926
2023-06-30 $727,096 18,096
2023-03-31 $407,656 9,547
2022-12-31 $388,144 8,083
2022-09-30 $287,453 7,641
2022-06-30 $190,342 6,889
2022-03-31 $372,719 6,854
2021-12-31 $359,835 6,150
2021-09-30 $243,056 6,144
2021-06-30 $153,953 3,625
2021-03-31 $210,254 3,416
2020-12-31 $245,479 3,480
2020-09-30 $32,321 838
2020-06-30 $42,311 1,128